3-(2-chlorophenothiazin-10-yl)-N-methylpropan-1-amine结构式
|
常用名 | 3-(2-chlorophenothiazin-10-yl)-N-methylpropan-1-amine | 英文名 | 3-(2-chlorophenothiazin-10-yl)-N-methylpropan-1-amine |
|---|---|---|---|---|
| CAS号 | 1225-64-5 | 分子量 | 304.83800 | |
| 密度 | 1.229g/cm3 | 沸点 | 458.2ºC at 760mmHg | |
| 分子式 | C16H17ClN2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 230.9ºC |
| 英文名 | 3-(2-chlorophenothiazin-10-yl)-N-methylpropan-1-amine |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.229g/cm3 |
|---|---|
| 沸点 | 458.2ºC at 760mmHg |
| 分子式 | C16H17ClN2S |
| 分子量 | 304.83800 |
| 闪点 | 230.9ºC |
| 精确质量 | 304.08000 |
| PSA | 40.57000 |
| LogP | 5.00810 |
| 蒸汽压 | 1.4E-08mmHg at 25°C |
| 折射率 | 1.627 |
| 海关编码 | 2934300000 |
|---|
|
~%
3-(2-chlorophen... 1225-64-5 |
| 文献:Kigondu, Elizabeth M.; Njoroge, Mathew; Singh, Kawaljit; Njuguna, Nicholas; Warner, Digby F.; Chibale, Kelly MedChemComm, 2014 , vol. 5, # 4 p. 502 - 506 |
|
~%
3-(2-chlorophen... 1225-64-5 |
| 文献:Fujii Yakugaku Zasshi, 1956 , vol. 76, p. 644,647, 648 Chem.Abstr., 1957 , p. 425 |
|
~%
3-(2-chlorophen... 1225-64-5 |
| 文献:Fujii Yakugaku Zasshi, 1956 , vol. 76, p. 644,647, 648 Chem.Abstr., 1957 , p. 425 |
|
~%
3-(2-chlorophen... 1225-64-5 |
| 文献:Huang; Guyton Journal of pharmaceutical sciences, 1969 , vol. 58, # 2 p. 267 - 270 |
| 海关编码 | 2934300000 |
|---|---|
| 中文概述 | 2934300000. 含一个吩噻嗪环系的化合物(吩噻嗪环系不论是否氢化,化合物未经进一步稠合的 ). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934300000. other compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.
Psychiatry Clin. Neurosci. 51(4) , 217-22, (1997) Thirty-seven newly admitted schizophrenic patients were treated with an open and flexible dosage of chlorpromazine for 3 months after receiving a test dose. Levels of chlorpromazine, demethylated chlo... |
|
|
Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
Psychopharmacology 73(1) , 55-62, (1981) Efforts to find a correlation between serum levels of chlorpromazine (CPZ) and clinical effect have been rather unsuccessful, which could be due to fluctuations of CPZ and CPZ metabolite levels during... |
|
|
[A microanalytical gas liquid chromatography method with a nitrogen-phosphorus detector in the assay of various psychotropic drugs of tricyclic structure and of their N-demethylated metabolites].
Boll. Soc. Ital. Biol. Sper. 60(9) , 1757-63, (1984) Nanogram amounts of chlorimipramine, chlorpromazine and their Nor1- and Nor2-metabolites were detected in plasma by GLC with nitrogen-sensitive detection. Two extraction procedures were compared. The ... |
| N-Desmethylchlorpromazine |
| NOR1-CHLORPROMAZINE |
| 10H-Phenothiazine-10-propanamine,2-chloro-N-methyl |
| UNII-O1G7LW1I5H |
| Norchlorpromazine |
| Chlorpromazine impurity D |
| 2-chloro-N-methyl-10H-phenothiazine-10-propanamine |
| N-Monodesmethylchlorpromazine |
| N-(3-methylaminopropyl)-2-chlorophenothiazine |
| [3-(2-chloro-phenothiazin-10-yl)-propyl]-methyl-amine |